The PML nuclear compartment and cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1288, Issue 3, 1996, Pages

  Doucas, Vassilis ^a   Evans, Ronald M ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; UNCLASSIFIED DRUG;

CANCER; CELL NUCLEUS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; NEOPLASM PROTEINS; NUCLEAR MATRIX; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0030443724     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(96)00028-5     Document Type: Review

References (38)

1. [1] Weber, A.F. and Frommes, S.P. (1963) Science 141, 912-913.
2. [2] Brasch, K. and Ochs, R.L. (1992) Exp. Cell. Res. 202, 211-223.
3. [3] Bernstein, R.M., Neuberger, J.M., Bunn, C.C., Callender, M.E., Hughes, G.R. and Williams, R. (1984) Clin. Exp. Immunol. 55, 553-560.
4. [4] Andrade, L.E., Chan, E.K., Raska, I., Peebles, C.L., Roos, G. and Tan, E.M. (1991) J. Exp. Med. 173, 1407-1419.
5. [5] Carmo-Fonseca, M., Pepperkok, R., Carvalho, M.T. and Lamond, A.I. (1992) J. Cell Biol. 117, 1-14.
6. [6] Carter, K.C., Bowman, D., Carrington, W., Fogarty, K., McNeil, J.A., Fay, F.S. and Lawrence, J.B. (1993) Science 259, 1330-1335.
7. [7] Huang, S., Deerinck, T.J., Ellisman, M.H. and Spector, D.L. (1994) J. Cell. Biol. 126, 877-899.
8. [8] Carmo-Fonseca, M., Ferreira, J. and Lamond, A.I. (1993) J. Cell. Biol. 120, 841-852.
9. [9] Bauer, D.W., Murphy, C, Wu. Z., Wu, C.H. and Gall, J.G. (1994) Mol. Biol. Cell. 5, 633-644.
10. [10] Jimenez-Garcia, L.F., Segura-Valdez, M.L., Ochs, R.L., Rothblum, L.I., Hannan, R. and Spector, D.L. (1994) Mol. Biol. Cell. 5, 955-966.
11. [11] Ascoli, C.A. and Maul, G.G. (1991) J. Cell. Biol. 112, 785-795.
12. [12] Dyck, J.A., Maul, G.G., Miller, W., Jr., Chen, J.D., Kakizuka, A. and Evans, R.M. (1994) Cell 76, 333-43.
13. [13] Koken, M.H., Puvion-Dutilleul, F., Guillemin, M.C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al. (1994) Embo J. 13, 1073-83.
14. [14] Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994) Cell 76, 345-356.
15. [15] Mitelman, F. (1988) Catalog of chromosome aberrations in cancer, 3rd ed. Allen Liss, New York.
16. []6] de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991) Cell 66, 675-684.
17. [17] Kakizuka, A., Miller, W., Jr., Umesono, K., Warrell, R., Jr., Frankel, S.R., Murty, V.V., Dmitrovsky, E. and Evans, R.M. (1991) Cell 66, 663-674.
18. [18] Pandolfi, P.P., Grignani, F., Alcalay, M., Mencarelli, A., Blondi, A., LoCoco, F., Grignani, F. and Pelicci, P.O. (1991) Oncogene 6, 1285-1292.
19. [19] Chang, K.S., Stass, S.A., Chu, D.T., Deaven, L.L., Trujillo, J.M. and Freireich, E.J. (1992) Mol. Cell. Biol. 12, 800-810.
20. [20] Goddard, A.D., Borrow, J. and Solomon, E. (1992) Leukemia 6, 117S-119S.
21. [21] Kastner, P., Ferez, A., Lutz, Y., Rochette-Egly, C., Gaub, M.P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Embo J. 11, 629-642.
22. [22] Doucas, V., Brockes, J.P., Yaniv, M., de Thé, H. and Dejean, A. (1993) Proc. Natl. Acad. Sci. USA 90, 9345-9349.
23. [23] Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C. and Chambon, P. (1993) Embo J. 12, 3171-3182.
24. [24] Borden, K.L., Boddy, M.N., Lally, J., O'Reilly, N.J., Martin, S., Howe, K., Solomon, E. and Freemont, P.S. (1995) Embo J. 14, 1532-1541.
25. [25] Sternsdorf, T., Guldner, H.H., Szostecki, C., Grotzinger, T. and Will, H. (1995) Scand. J. Immunol. 42, 257-268.
26. [26] Maul, G.G., Yu, E., Ishov, A.M. and Epstein, A.L. (1995) J. Cell Biochem. 59, 499-514.
27. [27] Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. and Wang, Z.Y. (1988) Blood 72, 567-572.
28. [28] Castaigne, S., Chomienne, C., Daniel, M.T., Ballerini, P., Berger, R., Fenaux, P. and Degos, L. (1990) Blood 76, 1704-1709.
29. [29] Early, E., Moore, M.A., S., Kakizuka, A., Nason-Burchenal, K., Martin, P., Evans, R.M. and Dmitrovsky, E. (1996) Proc. Natl. Acad. Sci. USA, in press.
30. [30] Grignani, F., Ferrucci, P.F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., etal. (1993) Cell 74, 423-431.
31. [31] Doucas, V., Ishov, A.M., Romo, A., Juguilon, H., Weitzman, M.D., Evans, R.M. and Maul, G.G. (1996) Genes Dev. 10, 196-207.
32. [32] Maul, G.G., Guldner, H.H. and Spivack, J.G. (1993) J. Gen. Virol. 74, 2679-2690.
33. [33] Kelly, C., Van Driel, R. and Wilkinson, G.W. (1995) J. Gen. Virol. 76, 2887-2893.
34. [34] Stadier, M., Chelbi-Alix, M.K., Koken, M.H., Venturini, L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M.C., Schindler, C., et al. (1995) Oncogene 11, 2565-2573.
35. [35] Doucas, V. and Evans, R.M. (1995) FASEB - Hematopoietic neopiasms: altered state of transcriptional regulation.
36. [36] Guiochoy-Mantel, A., Sarouvet, J.F., Quigyoy, F., Delabre, K., Milgrom, E. and de Thé, H. (1995) Mol. Endocrinol. 9, 1791-1803.
37. [37] Szostecki, C., Guldner, H.H., Netter, H.J., and Will, H. (1990) J. Immunol. 145, 4338-4347.
38. [38] Korioth, F., Gieffers, C., Maul, G.G. and Frey, J. (1995) J. Cell Biol. 130, 1-13.